Status:
NOT_YET_RECRUITING
Hepatocarcinoma Recurrence on the Liver Study - Part2
Lead Sponsor:
University of Milano Bicocca
Conditions:
Liver Cancer
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Rationale for the trial. To evaluate the impact of surgery on hepatocarcinoma recurrence. Thus, to evaluate the impact of different clinical, radiological, histopathological variables on recurrence af...
Detailed Description
Hepatocellular carcinoma (HCC) is 1 of the 5 most common malignancies worldwide and the third most common cause of cancer related mortality of 500,000 deaths globally every year. Although more common ...
Eligibility Criteria
Inclusion
- No age limit.
- Hepatocarcinoma diagnosis confirmed at histological specimen
- Every single patients with first HCC diagnosis or with a recurrence/persistence disease evaluated and treated with surgery at the participating center.
- the assessment for patient enrollment must have been performed starting from 02/02/2019.
Exclusion
- Surgery as a downstaging therapy for transplant
- Patients treated with surgery in case of not-curative intent (palliation, best supportive care, etc).
- Histopathological specimen of combined liver primary neoplasms (e.g. "hepatocholangiocarcinoma'').
- Patients with other tumors in the previous past.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2034
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04053231
Start Date
September 1 2019
End Date
May 1 2034
Last Update
August 12 2019
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Chirurgia Rubino - Policlinico di Bari
Bari, Italy
2
Ospedale Maggiore- AUSL
Bologna, Italy
3
Chirurgia Generale Bolzano
Bolzano, Italy
4
Fondazione Poliambulanza - Istituto Ospedaliero
Brescia, Italy